Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × INDUSTRY × ALX148 × Clear all

Phase

Status

Completed 3 Active not recruiting 3 Terminated 1 Recruiting 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

pembrolizumab 244 Carboplatin 171 Injections 137 Paclitaxel 124 Gemcitabine 117 Bevacizumab 116 Cisplatin 112 Pemetrexed 82 Docetaxel 81 Cyclophosphamide 67 Capecitabine 65 Fluorouracil 62 Oxaliplatin 58 Nivolumab 56 Fulvestrant 55 Cetuximab 53 130-nm albumin-bound paclitaxel 50 Leucovorin 47 fludarabine 46 Dexamethasone 45 atezolizumab 42 Rituximab 41 venetoclax 37 Drug Therapy 36 toripalimab 35 enzalutamide 34 durvalumab 33 Irinotecan 32 Lenalidomide 31 ribociclib 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07007559 2026-04-13

ASPEN-09-03

ALX Oncology Inc.

Phase 2 Recruiting

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡